CHARACTERIZATION OF MUCOSAL HEALING WITH ADALIMUMAB TREATMENT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE FROM EXTEND

(1) Mcmaster University, Hamilton, Canada

(2) Icahn School Of Medicine , New York, United States

(3) Academic Medical Center, Amsterdam, Netherlands

(4) Ucsd, La Jolla, United States

(5) U Of Leuven, Leuven, Belgium

(6) Abbvie Inc, North Chicago, United States

(7) Abbvie Inc, Rungis, France



This item was part of UEG Week 2014

This item can be cited as: United European Gastroenterology Journal; 2014: 2 (Supplement 1)